ConvaTec Group PLC logo

ConvaTec Group PLC

LSE:CTEC (UK)  
£ 2.53 (-0.32%) Jun 13
51.39
P/B:
3.86
Market Cap:
£ 5.19B ($ 6.61B)
Enterprise V:
£ 6.14B ($ 7.82B)
Volume:
5.83M
Avg Vol (2M):
5.90M
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for ConvaTec Group PLC ( LSE:CTEC ) from 2016 to Jun 14 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. ConvaTec Group PLC stock (LSE:CTEC) PE ratio as of Jun 14 2024 is 51.39. More Details

ConvaTec Group PLC (LSE:CTEC) PE Ratio (TTM) Chart

To

ConvaTec Group PLC (LSE:CTEC) PE Ratio (TTM) Historical Data

Total 1272
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
ConvaTec Group PLC PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-14 51.6 2024-04-09 59.1
2024-06-12 51.8 2024-04-08 58.6
2024-06-11 50.7 2024-04-05 58.4
2024-06-10 50.1 2024-04-04 59.0
2024-06-07 51.4 2024-04-03 59.9
2024-06-06 51.1 2024-04-02 59.9
2024-06-05 50.5 2024-03-28 58.5
2024-06-04 50.6 2024-03-27 59.0
2024-06-03 50.5 2024-03-26 59.1
2024-05-31 50.7 2024-03-25 58.6
2024-05-30 51.0 2024-03-22 59.0
2024-05-29 50.7 2024-03-21 58.9
2024-05-28 51.4 2024-03-20 57.7
2024-05-24 51.2 2024-03-19 58.3
2024-05-23 51.4 2024-03-18 58.8
2024-05-22 51.8 2024-03-15 58.9
2024-05-21 51.4 2024-03-14 58.7
2024-05-20 51.9 2024-03-13 57.8
2024-05-17 52.0 2024-03-12 57.1
2024-05-16 52.1 2024-03-11 57.3
2024-05-15 54.3 2024-03-08 58.4
2024-05-14 53.5 2024-03-07 56.2
2024-05-13 53.1 2024-03-06 54.6
2024-05-10 53.5 2024-03-05 51.5
2024-05-09 53.4 2024-03-04 51.1
2024-05-08 53.3 2024-03-01 51.1
2024-05-07 53.2 2024-02-29 50.2
2024-05-03 52.8 2024-02-28 50.3
2024-05-02 50.9 2024-02-27 50.8
2024-05-01 50.2 2024-02-26 51.2
2024-04-30 51.0 2024-02-23 50.7
2024-04-29 51.7 2024-02-22 50.5
2024-04-26 52.6 2024-02-21 50.0
2024-04-25 56.2 2024-02-20 49.4
2024-04-24 58.2 2024-02-19 50.0
2024-04-23 58.5 2024-02-16 49.8
2024-04-22 57.6 2024-02-15 49.3
2024-04-19 57.7 2024-02-14 48.9
2024-04-18 57.9 2024-02-13 47.9
2024-04-17 57.4 2024-02-12 48.6
2024-04-16 57.7 2024-02-09 48.8
2024-04-15 58.0 2024-02-08 47.9
2024-04-12 57.7 2024-02-07 48.7
2024-04-11 58.1 2024-02-06 48.6
2024-04-10 58.3 2024-02-05 48.3

ConvaTec Group PLC (LSE:CTEC) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue.